Skip to main content

Agios Pharmaceuticals, Inc.

AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001439222

In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Agios Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of AGIO: Q4 2021 compared with Q1 2022
MeasureQ4 2021Of which not filed for Q1 2022Q1 2022Change
Holders1612161+2
Shares59.2M11.7K59.9M+697.3K (+1.2%)
Value$1.95B$385.0K$1.74B−$203.5M (−10.5%)

2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (23)

Institutions that held Agios Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to AGIO in Q1 2022
InstitutionSharesValue% of portfolio
AXA S.A.200,837$5.85M0.02%
Boothbay Fund Management, LLC106,334$3.10M0.10%
Group One Trading, L.P.72,546$2.11M0.05%
Altium Capital Management LP66,196$1.93M0.67%
PDT Partners, LLC32,274$939.0K0.08%
Cowen and Company, LLC20,750$604.0K0.06%
Edgewood Management LLC20,000$582.0K0.00%
Jefferies Group LLC13,592$395.7K0.01%
Nomura Holdings Inc13,000$391.0K0.00%
HSBC Holdings PLC13,091$386.0K0.00%
E Fund Management Co., Ltd.8,923$260.0K0.01%
Jump Financial, LLC8,300$242.0K0.01%
Envestnet Asset Management Inc7,895$230.0K0.00%
Amalgamated Financial Corp.6,556$191.0K0.00%
Aquatic Capital Management LLC200$6.00K0.01%
Glassman Wealth Services100$3.00K0.00%
Prospera Financial Services Inc75$2.00K0.00%
Dark Forest Capital Management LP43$1.00K0.00%
Quent Capital, LLC23$1.00K0.00%
Ellevest, Inc.7$00.00%
Disciplined Investments, LLC2$00.00%
Cordant, Inc.5$00.00%
SJS Investment Consulting Inc.1$00.00%

Sold out (21)

Institutions that held Agios Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Not filed for Q1 2022 yet (2)

Institutions that held Agios Pharmaceuticals, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AGIO in Q4 2021 that haven't filed for Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
AlphaCentric Advisors LLC11,500$378.0K
Bell Investment Advisors, Inc213$7.00K